3 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Recruiting 3, Active not recruiting 1, Completed 1, Terminated 1, Unknown 1 |
Follow Diabetes, Gestational: new trials by email Literature Review of Diabetes, Gestational trials Research Report on Diabetes, Gestational
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM Insulin aspart - Gestational Diabetes, Endothelial Dysfunction | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 40 | 2024-10-01 | 2026-07-29 |
| Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes Metformin Hydrochloride, placebo - Gestational Diabetes | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 30 | 2024-09-11 | 2025-05-13 |
| Role of NADPH Oxidase in Microvascular Dysfunction Following GDM Acetylcholine, Insulin aspart - Gestational Diabetes, Oxidative Stress | Early Phase 1 | Active not recruiting | Anna Stanhewicz, PhD | 40 | 2023-08-30 | 2026-07-29 |
| Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes Acetylcholine, insulin aspart - Gestational Diabetes, Vascular Endothelial Function | Early Phase 1 | Recruiting | Anna Stanhewicz, PhD | 28 | 2023-07-01 | 2026-07-29 |
| Vitamin D Supplementation for the Prevention of GDM Vitamin D3, The placebo(not contain vitamin D) - Vitamin D, Gestational Diabetes | Early Phase 1 | Unknown | Women's Hospital School Of Medicine Zhejiang University | 1600 | 2022-01-01 | 2022-01-26 |
| Glyburide vs Glucovance in the Treatment of GDM Glyburide, Glucovance - Gestational Diabetes | Early Phase 1 | Terminated | Texas Tech University Health Sciences Center, El Paso | 7 | 2016-07-01 | 2020-10-12 |
| Soy Supplementation and Gestational Diabetes Soy Group (Soy Protein + Isoflavones), Control Group (Minimize Soy Intake) - Gestational Diabetes | Early Phase 1 | Completed | University of Massachusetts, Boston | 40 | 2013-01-01 | 2016-10-27 |
Diabetes Mellitus (1) · Sedentary Behavior (1)
Endocrine System Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Pregnancy Complications (7) · Urogenital Diseases (7) · Diabetes Mellitus (6) · Behavior (1)
Insulin Aspart (3) · Acetylcholine (2) · Metformin (2) · Cholecalciferol (1) · Control Groups (1) · Glucovance (1) · Glyburide (1) · Isoflavones (1) · Soybean Proteins (1)
Anna Stanhewicz, PhD (4) · Texas Tech University Health Sciences Center, El Paso (1) · University of Massachusetts, Boston (1) · Women's Hospital School Of Medicine Zhejiang University (1)
United States (6) · China (1)
Anna Stanhewicz, PhD (1) · Danqing Chen, doctor (1) · Ling Shi, PhD (1) · Lisa E Moore, MD (1)
R01HL169201 (3), F31HL177925 (1)